Cite
342 Novel Evidence for An Autocrine Mechanism By Which Neuropeptide Y Inhibits Cholangiocarcinoma Growth In Vitro and In Vivo
MLA
Mellanie White, et al. “342 Novel Evidence for An Autocrine Mechanism By Which Neuropeptide Y Inhibits Cholangiocarcinoma Growth In Vitro and In Vivo.” Gastroenterology, vol. 136, May 2009, p. A-799. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a91ef90e4288e0d434c07993521211b6&authtype=sso&custid=ns315887.
APA
Mellanie White, Paolo Onori, Antonio Franchitto, Shelley Kopriva, Eugenio Gaudio, Monique Coufal, Julie Venter, Guido Carpino, Heather Francis, Sharon DeMorrow, Giammarco Fava, & Gianfranco Alpini. (2009). 342 Novel Evidence for An Autocrine Mechanism By Which Neuropeptide Y Inhibits Cholangiocarcinoma Growth In Vitro and In Vivo. Gastroenterology, 136, A-799.
Chicago
Mellanie White, Paolo Onori, Antonio Franchitto, Shelley Kopriva, Eugenio Gaudio, Monique Coufal, Julie Venter, et al. 2009. “342 Novel Evidence for An Autocrine Mechanism By Which Neuropeptide Y Inhibits Cholangiocarcinoma Growth In Vitro and In Vivo.” Gastroenterology 136 (May): A-799. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a91ef90e4288e0d434c07993521211b6&authtype=sso&custid=ns315887.